124 related articles for article (PubMed ID: 10874450)
1. Serum and plasma parameters in clinical evaluation of neutropenic fever.
Südhoff T; Giagounidis A; Karthaus M
Antibiot Chemother (1971); 2000; 50():10-9. PubMed ID: 10874450
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of neutropenic fever: value of serum and plasma parameters in clinical practice.
Südhoff T; Giagounidis A; Karthaus M
Chemotherapy; 2000; 46(2):77-85. PubMed ID: 10671756
[TBL] [Abstract][Full Text] [Related]
3. Role of procalcitonin and CRP in differentiating a stable from a deteriorating clinical course in pediatric febrile neutropenia.
Secmeer G; Devrim I; Kara A; Ceyhan M; Cengiz B; Kutluk T; Buyukpamukcu M; Yetgin S; Tuncer M; Uludag AK; Tezer H; Yildirim I
J Pediatr Hematol Oncol; 2007 Feb; 29(2):107-11. PubMed ID: 17279007
[TBL] [Abstract][Full Text] [Related]
4. The predictive and diagnostic values of procalcitonin and C-reactive protein for clinical outcome in febrile neutropenic patients.
Erten N; Genc S; Besisik SK; Saka B; Karan MA; Tascioglu C
J Chin Med Assoc; 2004 May; 67(5):217-21. PubMed ID: 15357107
[TBL] [Abstract][Full Text] [Related]
5. Procalcitonin-a sensitive inflammation marker of febrile episodes in neutropenic children with cancer.
Fleischhack G; Cipic D; Juettner J; Hasan C; Bode U
Intensive Care Med; 2000 Mar; 26 Suppl 2():S202-11. PubMed ID: 18470721
[TBL] [Abstract][Full Text] [Related]
6. Soluble triggering receptor expressed on myeloid cells-1 as an infection marker for patients with neutropenic fever.
Lin CH; Yao M; Hsu SC; Ho CC; Lin MT; Lin CA; Hu FC; Yu CJ; Tien HF
Crit Care Med; 2011 May; 39(5):993-9. PubMed ID: 21283000
[TBL] [Abstract][Full Text] [Related]
7. Clinical value of serial measurement of serum C-reactive protein level in neutropenic patients.
Yonemori K; Kanda Y; Yamamoto R; Hamaki T; Suguro M; Chizuka A; Matsuyama T; Takezako N; Miwa A; Togawa A
Leuk Lymphoma; 2001 May; 41(5-6):607-14. PubMed ID: 11378578
[TBL] [Abstract][Full Text] [Related]
8. Assessment of systemic inflammation markers to differentiate a stable from a deteriorating clinical course in patients with febrile neutropenia.
Persson L; Söderquist B; Engervall P; Vikerfors T; Hansson LO; Tidefelt U
Eur J Haematol; 2005 Apr; 74(4):297-303. PubMed ID: 15777341
[TBL] [Abstract][Full Text] [Related]
9. Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II.
Fleischhack G; Kambeck I; Cipic D; Hasan C; Bode U
Br J Haematol; 2000 Dec; 111(4):1093-102. PubMed ID: 11167745
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.
El-Maghraby SM; Moneer MM; Ismail MM; Shalaby LM; El-Mahallawy HA
J Pediatr Hematol Oncol; 2007 Mar; 29(3):131-6. PubMed ID: 17356388
[TBL] [Abstract][Full Text] [Related]
11. The role of procalcitonin in febrile neutropenic patients: review of the literature.
Sakr Y; Sponholz C; Tuche F; Brunkhorst F; Reinhart K
Infection; 2008 Oct; 36(5):396-407. PubMed ID: 18759057
[TBL] [Abstract][Full Text] [Related]
12. TNF alpha, IL-1 beta and IL-6 plasma levels in neutropenic patients after onset of fever and correlation with the C-reactive protein (CRP) kinetic values.
Herrmann JL; Blanchard H; Brunengo P; Lagrange PH
Infection; 1994; 22(5):309-15. PubMed ID: 7531179
[TBL] [Abstract][Full Text] [Related]
13. Serum adenosine deaminase and procalcitonin concentrations in neutropenic febrile children with acute lymphoblastic leukaemia.
Hitoglou-Hatzi S; Hatzistilianou M; Gougoustamou D; Rekliti A; Agguridaki Ch; Athanassiadou F; Frydas S; Kotsis A; Catriu D
Clin Exp Med; 2005 Jul; 5(2):60-5. PubMed ID: 16096855
[TBL] [Abstract][Full Text] [Related]
14. Serum cortisol and inflammatory response in neutropenic fever.
Juutilainen A; Hämäläinen S; Niemenpää J; Kuittinen T; Pulkki K; Koivula I; Niskanen L; Jantunen E
Ann Hematol; 2011 Dec; 90(12):1467-75. PubMed ID: 21437589
[TBL] [Abstract][Full Text] [Related]
15. Do proinflammatory cytokine levels predict serious complication risk of infection in pediatric cancer patients?
Karakurt DG; Demirsoy U; Corapcioglu F; Oncel S; Karadogan M; Arisoy ES
Pediatr Hematol Oncol; 2014 Aug; 31(5):415-24. PubMed ID: 24499434
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Value of C-reactive Protein and Interleukin-8 in Risk Stratification of Febrile Neutropenic Children with Allogeneic Hematopoietic Stem Cell Transplantation.
Jaing TH; Chang CC; Chang TY; Chen SH; Wen YC; Tsay PK
Sci Rep; 2020 Feb; 10(1):2894. PubMed ID: 32076032
[TBL] [Abstract][Full Text] [Related]
17. Measurement of C-reactive protein in adults with febrile neutropenia after hematopoietic cell transplantation.
Ortega M; Rovira M; Almela M; de la Bellacasa JP; Carreras E; Mensa J
Bone Marrow Transplant; 2004 Apr; 33(7):741-4. PubMed ID: 14730343
[TBL] [Abstract][Full Text] [Related]
18. Use of inflammatory markers for early detection of bacteraemia in patients with febrile neutropenia.
Persson L; Engervall P; Magnuson A; Vikerfors T; Söderquist B; Hansson LO; Tidefelt U
Scand J Infect Dis; 2004; 36(5):365-71. PubMed ID: 15287382
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic value of interleukin-6 and interleukin-8 for early prediction of bacteremia and sepsis in children with febrile neutropenia and cancer.
Urbonas V; Eidukaitė A; Tamulienė I
J Pediatr Hematol Oncol; 2012 Mar; 34(2):122-7. PubMed ID: 22367386
[TBL] [Abstract][Full Text] [Related]
20. Plasma copeptin in the assessment of febrile neutropenia.
Purhonen AK; Vänskä M; Hämäläinen S; Pulkki K; Lehtikangas M; Kuittinen T; Nousiainen T; Koivula I; Jantunen E; Juutilainen A
Peptides; 2012 Jul; 36(1):129-32. PubMed ID: 22580173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
